Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
about
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosisMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusMOG antibody-related disorders: common features and uncommon presentations.Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.Pattern Recognition of the Multiple Sclerosis Syndrome.Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response
P2860
Q29036090-2BD30C7B-50ED-43C3-B830-D05DCEFD2930Q33645795-158D69B7-04CB-4C14-B8A1-1791730A70DEQ36827205-EC1C378A-2182-4265-A8F0-61EF46EDF10DQ38645211-A6D3AD63-5B25-45E1-9DEF-787F47204CCDQ39408205-C71AE39C-9AF7-4C20-9B77-E1717F3D6F55Q44875571-CB3DA256-D4D6-4012-A080-4EB2CDE2037AQ47096340-B3D97740-EA6B-4BDA-BF81-4D3D24D46AEFQ47284937-1AE52FC5-929B-48C9-8109-71E56B39697DQ48768047-7F6F1229-F62F-4108-AB68-4A443C0FA4ADQ52603606-21A8DB3C-574B-448F-8C80-0D4DFE62E118Q55221002-766A55AA-E589-4365-A0CD-DF5ABF07726DQ56673306-11E25F6E-80B5-4DF0-A143-6B91F843C55A
P2860
Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antibodies to myelin oligodend ...... l and prognostic implications.
@ast
Antibodies to myelin oligodend ...... l and prognostic implications.
@en
Antibodies to myelin oligodend ...... l and prognostic implications.
@nl
type
label
Antibodies to myelin oligodend ...... l and prognostic implications.
@ast
Antibodies to myelin oligodend ...... l and prognostic implications.
@en
Antibodies to myelin oligodend ...... l and prognostic implications.
@nl
prefLabel
Antibodies to myelin oligodend ...... l and prognostic implications.
@ast
Antibodies to myelin oligodend ...... l and prognostic implications.
@en
Antibodies to myelin oligodend ...... l and prognostic implications.
@nl
P2093
P2860
P50
P356
P1476
Antibodies to myelin oligodend ...... l and prognostic implications.
@en
P2093
Albert Saiz
David Brassat
María Sepúlveda
Romain Marignier
P2860
P304
P356
10.1177/1352458515591071
P577
2015-07-24T00:00:00Z